Phase I trial investigating the tolerability, pharmacokinetics and pharmacodynamics of olaratumab in patients with cancer
Latest Information Update: 15 Jan 2007
At a glance
- Drugs Olaratumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors ImClone Systems
- 15 Jan 2007 New trial record.